Zhang Yi, Wang Xi-Chao, Bao Xing-Fu, Hu Min, Yu Wei-Xian
Department of Orthodontics, School of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China.
Laboratory of Mechanism of Tooth Development and Bone Remodeling and Regeneration, School of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China.
Exp Ther Med. 2014 Jan;7(1):80-84. doi: 10.3892/etm.2013.1357. Epub 2013 Oct 23.
In bone remodeling, the Eph family is involved in regulating the process of osteoclast and osteoblast coordination in order to maintain bone homeostasis. In this study, the effects of lipopolysaccharide (Pg-LPS) on the osteoblast-osteoclast bidirectional EphB4-EphrinB2 signaling were investigated. An osteoblast-osteoclast co-culture system was achieved successfully. Hence, direct contact and communication between osteoblasts and osteoclasts was permitted. Regarding the protein expression and gene expression of EphB4 and EphrinB2, it was shown that Pg-LPS increased the expression of EphB4 while inhibiting the expression of EphrinB2. Therefore, the results indicate that, when treated with Pg-LPS, the EphB4 receptor on osteoblasts and the EphrinB2 ligand on osteoclasts may generate bidirectional anti-osteoclastogenic and pro-osteoblastogenic signaling into respective cells and potentially facilitate the transition from bone resorption to bone formation. This study may contribute to the control of osteoblast differentiation and bone formation at remodeling, and possibly also modeling, sites.
在骨重塑过程中,Eph家族参与调节破骨细胞与成骨细胞的协同过程,以维持骨稳态。在本研究中,研究了牙龈卟啉单胞菌脂多糖(Pg-LPS)对成骨细胞-破骨细胞双向EphB4-EphrinB2信号传导的影响。成功建立了成骨细胞-破骨细胞共培养体系。因此,成骨细胞与破骨细胞之间实现了直接接触和通讯。关于EphB4和EphrinB2的蛋白表达和基因表达,结果显示Pg-LPS增加了EphB4的表达,同时抑制了EphrinB2的表达。因此,结果表明,用Pg-LPS处理时,成骨细胞上的EphB4受体和破骨细胞上的EphrinB2配体可能会在各自细胞中产生双向抗破骨细胞生成和促骨细胞生成信号,并可能促进从骨吸收到骨形成的转变。本研究可能有助于在重塑部位以及可能的建模部位控制成骨细胞分化和骨形成。
ACS Infect Dis. 2024-4-12
Adv Exp Med Biol. 2010
Zhongguo Gu Shang. 2013-8
In Vitro Cell Dev Biol Anim. 2016-2
Cell Metab. 2006-8
Pharmaceuticals (Basel). 2023-2-15
J Immunol Res. 2014-3-25
J Clin Invest. 2012-10-1
Nature. 2010-5-27
Adv Exp Med Biol. 2010
Arch Biochem Biophys. 2008-5-15
Biochem Biophys Res Commun. 2007-8-24
Trends Cell Biol. 2007-5
Cell. 2006-8-11